Reviewing Progress: 7 year Trends in Characteristics of Adults and Children Enrolled at HIV Care and Treatment Clinics in the United Republic of Tanzania

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2013 Oct 29

PMID 24160907

Citations 10

Authors

Harriet Nuwagaba-Biribonwoha

Bonita Kilama

Gretchen Antelman

Ahmed Khatib

Annette Almeida

William Reidy

Gongo Ramadhani

Matthew R Lamb

Redempta Mbatia

Elaine J Abrams

Affiliations

Soon will be listed here.

Abstract

Background: To evaluate the on-going scale-up of HIV programs, we assessed trends in patient characteristics at enrolment and ART initiation over 7 years of implementation.

Methods: Data were from Optimal Models, a prospective open cohort study of HIV-infected (HIV+) adults (≥15 years) and children (<15 years) enrolled from January 2005 to December 2011 at 44 HIV clinics in 3 regions of mainland Tanzania (Kagera, Kigoma, Pwani) and Zanzibar. Comparative statistics for trends in characteristics of patients enrolled in 2005-2007, 2008-2009 and 2010-2011 were examined.

Results: Overall 62,801 HIV + patients were enrolled: 58,102(92.5%) adults, (66.5% female); 4,699(7.5%) children.Among adults, pregnant women enrolment increased: 6.8%, 2005-2007; 12.1%, 2008-2009; 17.2%, 2010-2011; as did entry into care from prevention of mother-to-child HIV transmission (PMTCT) programs: 6.6%, 2005-2007; 9.5%, 2008-2009; 12.6%, 2010-2011. WHO stage IV at enrolment declined: 27.1%, 2005-2007; 20.2%, 2008-2009; 11.1% 2010-2011. Of the 42.5% and 29.5% with CD4+ data at enrolment and ART initiation respectively, median CD4+ count increased: 210 cells/μL, 2005-2007; 262 cells/μL, 2008-2009; 266 cells/μL 2010-2011; but median CD4+ at ART initiation did not change (148 cells/μL overall). Stavudine initiation declined: 84.9%, 2005-2007; 43.1%, 2008-2009; 19.7%, 2010-2011.Among children, median age (years) at enrolment decreased from 6.1(IQR:2.7-10.0) in 2005-2007 to 4.8(IQR:1.9-8.6) in 2008-2009, and 4.1(IQR:1.5-8.1) in 2010-2011 and children <24 months increased from 18.5% to 26.1% and 31.5% respectively. Entry from PMTCT was 7.0%, 2005-2007; 10.7%, 2008-2009; 15.0%, 2010-2011. WHO stage IV at enrolment declined from 22.9%, 2005-2007, to 18.3%, 2008-2009 to 13.9%, 2010-2011. Proportion initiating stavudine was 39.8% 2005-2007; 39.5%, 2008-2009; 26.1%, 2010-2011. Median age at ART initiation also declined significantly.

Conclusions: Over time, the proportion of pregnant women and of adults and children enrolled from PMTCT programs increased. There was a decline in adults and children with advanced HIV disease at enrolment and initiation of stavudine. Pediatric age at enrolment and ART initiation declined. Results suggest HIV program maturation from an emergency response.

Citing Articles

HIV care and treatment clinic performance following President's Emergency Plan for AIDS Relief-funded infrastructure improvement in Tanzania.

Idindili B, King S, Stolka K, Mashasi I, Bashosho P, Karungula H South Afr J HIV Med. 2024; 19(1):777.

PMID: 39449987 PMC: 11500648. DOI: 10.4102/sajhivmed.v19i1.777.

Factors Associated with Treatment Outcomes Among Children and Adolescents Living with HIV Receiving Antiretroviral Therapy in Central Kenya.

McLigeyo A, Wekesa P, Owuor K, Mwangi J, Isavwa L, Mutisya I AIDS Res Hum Retroviruses. 2022; 38(6):480-490.

PMID: 35229643 PMC: 9225829. DOI: 10.1089/AID.2021.0112.

Temporal trends in pre-ART patient characteristics and outcomes before the test and treat era in Central Kenya.

Wekesa P, McLigeyo A, Owuor K, Mwangi J, Isavwa L, Katana A BMC Infect Dis. 2021; 21(1):1007.

PMID: 34565337 PMC: 8474838. DOI: 10.1186/s12879-021-06706-3.

The effects of decentralising antiretroviral therapy care delivery on health outcomes for adolescents and young adults in low- and middle-income countries: a systematic review.

Haghighat R, Steinert J, Cluver L Glob Health Action. 2019; 12(1):1668596.

PMID: 31558145 PMC: 6781195. DOI: 10.1080/16549716.2019.1668596.

Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004-2015 retrospective cohort study.

Mecha J, Kubo E, Nganga L, Muiruri P, Njagi L, Ilovi S HIV AIDS (Auckl). 2018; 10:103-114.

PMID: 29988689 PMC: 6029585. DOI: 10.2147/HIV.S153185.

References

Nuwagaba-Biribonwoha H, Werq-Semo B, Abdallah A, Cunningham A, Gamaliel J, Mtunga S . Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania. BMC Pediatr. 2010; 10:44. PMC: 2907368. DOI: 10.1186/1471-2431-10-44. View

Birungi J, Mills E . Can we increase male involvement in AIDS treatment?. Lancet. 2010; 376(9749):1302. DOI: 10.1016/S0140-6736(10)61918-6. View

Reece M, Hollub A, Nangami M, Lane K . Assessing male spousal engagement with prevention of mother-to-child transmission (pMTCT) programs in western Kenya. AIDS Care. 2010; 22(6):743-50. DOI: 10.1080/09540120903431330. View

Hawkins C, Chalamilla G, Okuma J, Spiegelman D, Hertzmark E, Aris E . Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS. 2011; 25(9):1189-97. DOI: 10.1097/QAD.0b013e3283471deb. View

Kouanfack C, Laborde-Balen G, Aghokeng A, Bourgeois A, Dontsop M, Mben J . WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations. Trop Med Int Health. 2010; 15(5):580-3. DOI: 10.1111/j.1365-3156.2010.02495.x. View

. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc. 2011; 14:7. PMC: 3058075. DOI: 10.1186/1758-2652-14-7. View

Geng E, Hunt P, Diero L, Kimaiyo S, Somi G, Okong P . Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. J Int AIDS Soc. 2011; 14:46. PMC: 3204275. DOI: 10.1186/1758-2652-14-46. View

Somi G, Matee M, Makene C, van den Hombergh J, Kilama B, Yahya-Malima K . Three years of HIV/AIDS care and treatment services in Tanzania: achievements and challenges. Tanzan J Health Res. 2010; 11(3):136-43. DOI: 10.4314/thrb.v11i3.47700. View

Peltzer K, Jones D, Weiss S, Shikwane E . Promoting male involvement to improve PMTCT uptake and reduce antenatal HIV infection: a cluster randomized controlled trial protocol. BMC Public Health. 2011; 11:778. PMC: 3196716. DOI: 10.1186/1471-2458-11-778. View

10.

Duda S, Shepherd B, Gadd C, Masys D, McGowan C . Measuring the quality of observational study data in an international HIV research network. PLoS One. 2012; 7(4):e33908. PMC: 3320898. DOI: 10.1371/journal.pone.0033908. View

11.

Anema A, Zhang W, Wu Y, Elul B, Weiser S, Hogg R . Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries. Public Health Nutr. 2011; 15(5):938-47. PMC: 5341131. DOI: 10.1017/S136898001100125X. View

12.

Koo K, Makin J, Forsyth B . Where are the men? Targeting male partners in preventing mother-to-child HIV transmission. AIDS Care. 2012; 25(1):43-8. DOI: 10.1080/09540121.2012.687822. View

13.

Baveewo S, Ssali F, Karamagi C, Kalyango J, Hahn J, Ekoru K . Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda. PLoS One. 2011; 6(5):e19089. PMC: 3093378. DOI: 10.1371/journal.pone.0019089. View

14.

Lahuerta M, Lima J, Elul B, Okamura M, Alvim M, Nuwagaba-Biribonwoha H . Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011; 58(3):e75-86. PMC: 3422887. DOI: 10.1097/QAI.0b013e31822ac0a9. View

15.

Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, Okamura M, Alvim M, Fernandes R . Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS One. 2012; 7(5):e37125. PMC: 3352894. DOI: 10.1371/journal.pone.0037125. View

16.

Ahonkhai A, Noubary F, Munro A, Stark R, Wilke M, Freedberg K . Not all are lost: interrupted laboratory monitoring, early death, and loss to follow-up (LTFU) in a large South African treatment program. PLoS One. 2012; 7(3):e32993. PMC: 3299719. DOI: 10.1371/journal.pone.0032993. View

17.

Lambdin B, Micek M, Koepsell T, Hughes J, Sherr K, Pfeiffer J . An assessment of the accuracy and availability of data in electronic patient tracking systems for patients receiving HIV treatment in central Mozambique. BMC Health Serv Res. 2012; 12:30. PMC: 3293775. DOI: 10.1186/1472-6963-12-30. View

18.

Moon T, Burlison J, Blevins M, Shepherd B, Baptista A, Sidat M . Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president's emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS. 2011; 22(11):621-7. DOI: 10.1258/ijsa.2011.010442. View

19.

Boyer S, Eboko F, Camara M, Abe C, Nguini M, Koulla-Shiro S . Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS. 2009; 24 Suppl 1:S5-15. DOI: 10.1097/01.aids.0000366078.45451.46. View

20.

Kiragga A, Castelnuovo B, Schaefer P, Muwonge T, Easterbrook P . Quality of data collection in a large HIV observational clinic database in sub-Saharan Africa: implications for clinical research and audit of care. J Int AIDS Soc. 2011; 14:3. PMC: 3037294. DOI: 10.1186/1758-2652-14-3. View